These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20441117)

  • 1. Pharmaceutical industry funding of educational events for pharmacists in Australia: an analysis of data from the first 6 months of a mandatory disclosure programme.
    Robertson J; Walkom E; Moynihan R; Bero L; Henry D
    Int J Pharm Pract; 2010 Apr; 18(2):88-92. PubMed ID: 20441117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Views of pharmacist prescribers, doctors and patients on pharmacist prescribing implementation.
    Stewart DC; George J; Bond CM; Diack HL; McCaig DJ; Cunningham S
    Int J Pharm Pract; 2009 Apr; 17(2):89-94. PubMed ID: 20214256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuing professional pharmacy development needs assessment of Qatar pharmacists.
    Wilbur K
    Int J Pharm Pract; 2010 Aug; 18(4):236-41. PubMed ID: 20636676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia.
    Fabbri A; Grundy Q; Mintzes B; Swandari S; Moynihan R; Walkom E; Bero LA
    BMJ Open; 2017 Jun; 7(6):e016701. PubMed ID: 28667226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospital pharmacists' knowledge and opinions regarding adverse drug reaction reporting in Northern China.
    Su C; Ji H; Su Y
    Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):217-22. PubMed ID: 20033911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a pharmacist on the educational value of pharmaceutical industry film showings.
    Bayliff CD; Edington RD; Johnston LJ; Shaw PW; Bailey DG
    Can J Hosp Pharm; 1991 Dec; 44(6):283-7. PubMed ID: 10116487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events.
    MacLaren R; Bond CA
    Pharmacotherapy; 2009 Jul; 29(7):761-8. PubMed ID: 19558249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmaceutical care of patients with diabetes mellitus and its relationship to clinical pharmacy].
    Vlcek J; Malý J; Dosedel M
    Vnitr Lek; 2009 Apr; 55(4):384-8. PubMed ID: 19449755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting suboptimal prescribing in the elderly: a review of the impact of pharmacy services.
    Castelino RL; Bajorek BV; Chen TF
    Ann Pharmacother; 2009 Jun; 43(6):1096-106. PubMed ID: 19470856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Giving and receiving of gifts between pharmaceutical companies and medical specialists in Australia.
    McNeill PM; Kerridge IH; Henry DA; Stokes B; Hill SR; Newby D; Macdonald GJ; Day RO; Maguire J; Henderson KM
    Intern Med J; 2006 Sep; 36(9):571-8. PubMed ID: 16911549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a pharmacist-led, medicines education program for Aboriginal Health Workers.
    McRae M; Taylor SJ; Swain L; Sheldrake C
    Rural Remote Health; 2008; 8(4):946. PubMed ID: 19093711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The extent and characteristics of United Kingdom hospital pharmacists keeping, or not keeping, a professional development portfolio.
    Kostrzewski AJ; Dhillon S; Goodsman D; Taylor KM; Weinman JA
    Int J Pharm Pract; 2009 Oct; 17(5):299-304. PubMed ID: 20214272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Professional-development and continuing-education programs for pharmacists in large hospitals.
    Craig SA; Clark T
    Am J Hosp Pharm; 1988 Dec; 45(12):2503-6. PubMed ID: 3228102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacists' attitudes towards the reporting of suspected adverse drug reactions in Norway.
    Granas AG; Buajordet M; Stenberg-Nilsen H; Harg P; Horn AM
    Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):429-34. PubMed ID: 16953518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Satisfaction of pharmacists in Lebanon and the prospect for clinical pharmacy].
    Antoun RB; Salameh P
    East Mediterr Health J; 2009; 15(6):1553-63. PubMed ID: 20218149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparing hospital pharmacists to prescribe: stakeholders' views of postgraduate courses.
    Kamarudin G; Penm J; Chaar B; Moles R
    Int J Pharm Pract; 2013 Aug; 21(4):243-51. PubMed ID: 23418670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive measure of pharmaceutical services: the pharmaceutical-care index.
    Pitterle ME; Bond CA; Raehl CL
    Am J Hosp Pharm; 1990 Jun; 47(6):1304-13. PubMed ID: 2368723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General practitioner-pharmacist interactions in professional pharmacy services.
    Van C; Mitchell B; Krass I
    J Interprof Care; 2011 Sep; 25(5):366-72. PubMed ID: 21657854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacists' documentation in patients' hospital health records: issues and educational implications.
    Pullinger W; Franklin BD
    Int J Pharm Pract; 2010 Apr; 18(2):108-15. PubMed ID: 20441120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.